Related Experiment Video
Updated: Jun 27, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic cardiomyopathy: individualized therapy for a heterogeneous disease
1Hypertrophic Cardiomyopathy Program and the Echocardiography Laboratory Division of Cardiology, Department of Medicine St. Luke's, Roosevelt Hospital Center Columbia University College of Physicians and Surgeons New York City, NY, USA. msherrid@chpnet.org
Abstract:
It is now 50 years since the modern description of hypertrophic cardiomyopathy (HCM). The initial descriptions foretold the current efforts towards sudden death prevention, alleviation of heart failure symptoms and angina, relief of left ventricular outflow tract obstruction, preparticipation athletic screening, family screening and genetic testing. The authors review the salient features of HCM, focusing on therapeutic strategies to manage its symptoms and attempts to prevent sudden death.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy

